W
Wei Li
Researcher at University of Pittsburgh
Publications - 33
Citations - 995
Wei Li is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Antibody & Epitope. The author has an hindex of 11, co-authored 33 publications receiving 571 citations. Previous affiliations of Wei Li include Fudan University & Tsinghua University.
Papers
More filters
Journal ArticleDOI
Dual role of mitochondria in producing melatonin and driving GPCR signaling to block cytochrome c release
Yalikun Suofu,Wei Li,Wei Li,Frederic Jean-Alphonse,Jiaoying Jia,Nicolas K Khattar,Jiatong Li,Jiatong Li,Sergei V. Baranov,Daniela Leronni,Amanda C. Mihalik,Yanqing He,Erika Cecon,Erika Cecon,Vanessa L. Wehbi,Jinho Kim,Brianna Heath,Oxana V. Baranova,Xiaomin Wang,Matthew J. Gable,Eric S. Kretz,Giulietta Di Benedetto,Timothy R. Lezon,Lisa M. Ferrando,Timothy M. Larkin,Mara Sullivan,Svitlana Yablonska,Jingjing Wang,Jingjing Wang,M. Beth Minnigh,Gérald Guillaumet,Franck Suzenet,R. Mark Richardson,Samuel M. Poloyac,Donna B. Stolz,Ralf Jockers,Ralf Jockers,Paula A. Witt-Enderby,Diane L. Carlisle,Jean-Pierre Vilardaga,Robert M. Friedlander +40 more
TL;DR: The finding that mitochondria synthesize and release melatonin and have their selective G protein-coupled receptor (GPCR) in the outer membrane is described and a new term, “automitocrine,” is proposed to describe this unexpected intracellular organelle ligand–receptor pathway that opens a new research avenue investigating mitochondrial GPCR biology.
Journal ArticleDOI
Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies.
Xing Zhu,Dhiraj Mannar,Shanti Swaroop Srivastava,Alison M. Berezuk,Jean-Philippe Demers,James W. Saville,Karoline Leopold,Wei Li,Dimiter S. Dimitrov,Katharine Tuttle,Steven Zhou,Sagar Chittori,Sriram Subramaniam +12 more
TL;DR: In this article, a 2.9-A resolution structure of the complex between the ACE2 receptor and N501Y spike protein ectodomains was presented, showing that Y501 inserted into a cavity at the binding interface near Y41 of ACE2.
Journal ArticleDOI
High Potency of a Bivalent Human VH Domain in SARS-CoV-2 Animal Models
Wei Li,Alexandra Schäfer,Swarali S. Kulkarni,Xianglei Liu,David R. Martinez,Chuan Chen,Zehua Sun,Sarah R. Leist,Aleksandra Drelich,Liyong Zhang,Marcin Ura,Alison M. Berezuk,Sagar Chittori,Karoline Leopold,Dhiraj Mannar,Shanti Swaroop Srivastava,Xing Zhu,Eric C. Peterson,Chien Te K. Tseng,John W. Mellors,Darryl Falzarano,Sriram Subramaniam,Ralph S. Baric,Dimiter S. Dimitrov +23 more
TL;DR: The potent neutralization activity of VH-Fc ab8 combined with good developability properties and cross-reactivity to SARS-CoV-2 mutants provide a strong rationale for its evaluation as a COVID-19 therapeutic.
Journal ArticleDOI
Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection.
Wei Li,Chuan Chen,Aleksandra Drelich,David R. Martinez,Lisa E. Gralinski,Zehua Sun,Alexandra Schäfer,Swarali S. Kulkarni,Xianglei Liu,Sarah R. Leist,Doncho V. Zhelev,Liyong Zhang,Ye-Jin Kim,Eric C. Peterson,Alex Conard,John W. Mellors,Chien-Te K Tseng,Darryl Falzarano,Ralph S. Baric,Dimiter S. Dimitrov +19 more
TL;DR: A fully human monoclonal germline-like antibody (ab1) from phage-displayed libraries that potently inhibited mouse ACE2-adapted SARS-CoV-2 replication in wild-type BALB/c mice and native virus in transgenic mice expressing human ACE2 as well as in hamsters when administered before virus challenge.
Journal ArticleDOI
Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs
Mark Yarmarkovich,Quinlen F. Marshall,John M. Warrington,Rasika Premaratne,Alvin Farrel,David Groff,Wei Li,Moreno Di Marco,Erin Runbeck,Hau Truong,Jugmohit S. Toor,Sarvind Tripathi,Son Nguyen,Helena Shen,Tiffany Noel,Nicole L. Church,Amber K. Weiner,Nathan M. Kendsersky,Daniel Martinez,Rebecca Weisberg,Molly Christie,Laurence C. Eisenlohr,Kristopher R. Bosse,Kristopher R. Bosse,Dimiter S. Dimitrov,Stefan Stevanovic,Nikolaos G. Sgourakis,Ben R. Kiefel,John M. Maris,John M. Maris +29 more
TL;DR: In this article, a peptide-centric chimeric antigen receptor (CAR) was proposed to target unmutated peptide QYNPIRTTF, discovered on HLA-A*24:02, derived from the neuroblastoma dependency gene and master transcriptional regulator PHOX2B.